News in brief: Vitura signs MedReleaf deal; Neurotech initiates first site for Phase 3 autism trial by Adam Sheldon March 17, 2026March 17, 2026 Vitura Health has signed its first distribution agreement with MedReleaf Australia. Under the deal, MedReleaf – […]
News in brief: Epsilon launches biotech arm; LGP sells WA facility for $7.8m; Neurotech partners with University of Sydney on Rett program by Adam Sheldon February 18, 2026February 19, 2026
Cannabinoid drug developer holds ‘positive’ talks with TGA as hopes rise of fast-tracking ARTG listing by Steve Jones June 28, 2024June 28, 2024
